NUR HOLDINGS to Issue 112 Million Subscription Shares

Stock News05-28

NUR HOLDINGS (00254) announced that on a date in May 2026, the company entered into three separate conditional subscription agreements with three subscribers: Zheng Kaibin, Meng Lufang, and Fu Shanghui. According to the subscription agreements, the subscribers conditionally agreed to subscribe for, and the company conditionally agreed to allot and issue, a total of 112 million subscription shares at a subscription price of HK$0.77 per share. The 112 million subscription shares to be allotted and issued to the subscribers represent approximately 19.87% of the total issued shares as of the date of this announcement, and approximately 16.57% of the total issued shares as enlarged by the issuance and allotment of all subscription shares (assuming no change in the total number of issued shares prior to the completion date). The total gross proceeds and net proceeds from the subscription are expected to be approximately HK$86.24 million and HK$86.14 million, respectively. The company intends to use approximately 40% of the net proceeds to develop its trading business, including but not limited to the trade of frozen or fresh products; approximately 40% for investment activities when opportunities arise; and the remaining approximately 20% as general working capital to strengthen the company's financial position.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment